Overview

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This study will investigate the steroid sparing effect of pimecrolimus cream 1% in pediatric atopic dermatitis
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Pimecrolimus
Tacrolimus